Seasonal depression doesn't usually work this way, but with the news that Audi is removing one of its few convertibles from the lineup, there's nothing wrong with getting a little weepy in the middle of summer.
Audi will discontinue its A3 Cabriolet after the 2019 model year, Car and Driver reports.
It's not bringing the executioner's ax down on every A3 variant, just the drop-top, so A3 sedan fans don't have anything to worry about for the 2020 model year.
Thankfully, you can still scoop up one of the 2019 models while they're at dealers.
Each of the A3 Cabriolet's three trims can be had with one of two powertrains.
The base 2.0-liter I4 puts out 184 horsepower and 222 pound-feet of torque, and it comes mated to a seven-speed dual-clutch automatic transmission and front-wheel drive.
German automakers made several attempts to bring their cheaper entry-level options to the US market, but the Audi A3 was the first to make it stick.
Introduced as a hatchback-only model in 2006, the A3 shifted to a sedan body in 2015, along with a convertible model offered for a short time.Read more - 2022 Audi A3 Sedan Test Drive Review: Value And Luxury Collide
Seasonal Affective Disorder Market information: by type (fall and winter SAD, and others), by diagnosis (physical exam, lab tests, and others), by treatment (light therapy, medications, and others), by end user- global forecast till 2027Market Analysis The global seasonal affective disorder market is predicted to touch USD 694.9 million at a 4.2% CAGR by 2023, as per the latest Market Research Future (MRFR) report.
Based on type, the seasonal affective disorder market is segmented into spring and summer SAD, fall and winter SAD, and others.
The psychological evaluation segment is again segmented into direct observation tests, vocational tests, neuropsychological tests, aptitude tests, achievement tests, attitude tests, personality tests, and intelligence tests.
Regional Analysis By region, the seasonal affective disorder market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA).
This is owing to growing awareness, changing lifestyle, availability of products and treatments, and developing health facilities.
This is owing to limited access to healthcare facilities, less awareness about seasonal affective disorder, and low prevalence rate.